Skip to main content
. 2015 Aug 20;10(10):970–980. doi: 10.1080/15592294.2015.1085140

Figure 5.

Figure 5.

Individual and combined effect of LRIG1 loss and hypermethylation on clinical outcome. Kaplan-Meier curves of progression free survival for cervical cancer patients (cohort 1) with and without loss of LRIG1 (A), with and without hypermethylation of LRIG1 (B), the 2 combined (C), and high and low LRIG1 expression (D). P-values in log-rank test and number of patients are indicated. NL: no loss; L: loss; NM: not hypermethylated; M: hypermethylated.